| 词条 | Pharmaceutical Research and Manufacturers of America |
| 释义 |
In 2017, the organization had revenue of $455 million, $128 million of which was spent on lobbying activities.[4] LeadershipGeorge A. Scangos, CEO of Biogen, is chairman of the PhRMA board. Joaquin Duato, chairman of Johnson & Johnson's pharmaceutical division, is chairman-elect and Joseph Jimenez, CEO of Novartis, is board treasurer.[5] Previous leadership includes: John J. Castellani, formerly head of the Business Roundtable, a U.S. advocacy and lobbying group[6] and Billy Tauzin, a former Republican congressman from Louisiana.[7][8][9] The company has notably opposed market pricing strategies of Valeant Pharmaceuticals, deriding the firm as having a strategy "reflective of a hedge fund".[10] ProgramsSMARxT Disposal is a joint program run by the U.S. Fish and Wildlife Service, the American Pharmacists Association, and PhRMA to encourage consumers to properly dispose of unused medicines to avoid harm to the environment.[11] The Partnership for Prescription Assistance is a program by PhRMA and its member companies that connects patients in-need with information on low-cost and free prescription medication.[11] PhRMA has in 2017 raised concerns over price increases for generic drugs out of patent by the company Marathon Pharmaceuticals over Duchenne muscular dystrophy treatment.[12] The company has advocated abroad in South Africa regarding pharmaceutical drug intellectual property rules.[13] In January 2018, the organization introduced the "Let's Talk About Cost" website, which makes the argument that much of the cost of medication goes to middlemen unassociated with pharmaceutical companies.[14][4] Related Sites[https://www.phrma.org/ Phrma.org] [https://www.letstalkaboutcost.org/ Let's Talk About Cost] See also
References1. ^1 {{Cite news|url=http://www.nationalhealthcouncil.org/about-nhc/members/pharmaceutical-research-and-manufacturers-america|title=Pharmaceutical Research and Manufacturers of America|date=2014-11-04|work=National Health Council|access-date=2017-12-11|language=en}} 2. ^{{cite news |author=The Editorial Board |title=Turn the Volume Down on Drug Ads |url=https://www.nytimes.com/2015/11/27/opinion/turn-the-volume-down-on-drug-ads.html |date=November 27, 2015 |work=New York Times |accessdate=November 27, 2015 }} 3. ^Stephen J. Ubl to Lead PhRMA as Next President and CEO. PhRMA website. September 25, 2015 4. ^1 {{Cite news|url=https://www.mmm-online.com/home/channel/commercial/phrma-spent-nearly-10-times-2016s-sum-on-advertising-last-year/|title=PhRMA spent nearly 10 times 2016’s sum on advertising last year|last=Kanski|first=Alison|date=November 26, 2018|work=|access-date=}} 5. ^{{cite web | url = http://phrma.org/media-releases/biogen-ceo-george-a-scangos-becomes-phrma-board-chairman | title = Biogen CEO George A. Scangos Becomes PhRMA Board Chairman | publisher = PhRMA | date = March 10, 2016}} 6. ^whorunsgov.com {{webarchive|url=https://web.archive.org/web/20110127013251/http://www.whorunsgov.com/Profiles/John_Castellani |date=January 27, 2011 }} 7. ^{{Cite news | title = Pharmaceutical group shifts tone with new pick for president | author = N.C. Alzenman and Dan Eggen | publisher = The Washington Post | date = July 14, 2010 | url = https://www.washingtonpost.com/wp-dyn/content/article/2010/07/13/AR2010071302891.html}} 8. ^{{cite news | author = Judy Sarasohn | url = https://www.washingtonpost.com/wp-dyn/articles/A3504-2004Dec15.html | title = Special Interests: Tauzin to Head Drug Trade Group | publisher = The Washington Post | date = December 16, 2004 | page = A35}} 9. ^{{cite news | author = Julian Pecquet | title = PhRMA picks new president | publisher = The Hill | date = July 14, 2010 | volume = 17 | issue = 81 | page = 22}} 10. ^{{Cite web|url=https://www.economist.com/news/united-states/21711333-president-elect-formerly-pharma-industrys-preferred-candidate-has-promised-bring|title=High price tags for medicines are about to come under renewed pressure|website=The Economist|language=en|access-date=2018-02-12}} 11. ^1 {{cite web|url=http://www.phrma.org/research/patient-resources |title=Patient Resources |publisher=Pharmaceutical Research and Manufacturers of America |accessdate=April 6, 2011 |deadurl=yes |archiveurl=https://web.archive.org/web/20110319121101/http://www.phrma.org/research/patient-resources |archivedate=March 19, 2011 }} 12. ^{{Cite news|url=https://arstechnica.com/science/2017/02/marathon-gets-the-shkreli-treatment-from-industry-after-89k-drug-dust-up/|title=Marathon gets the Shkreli treatment from industry after $89K drug dust up|newspaper=Ars Technica|access-date=2017-02-18|language=en-us}} 13. ^{{Cite web|url=https://www.economist.com/blogs/schumpeter/2014/01/new-drug-war-continued|title=Leaky pharma|website=The Economist|language=en|access-date=2018-02-12}} 14. ^{{Cite web|url=https://catalyst.phrma.org/phrma-launches-new-consumer-facing-lets-talk-about-cost-website|title=PhRMA launches new consumer-facing Let’s Talk About Cost website|last=Campbell|first=Holly|date=January 24, 2018|website=|archive-url=|archive-date=|dead-url=|access-date=}} External links
7 : Pharmaceutical companies of the United States|1958 establishments in the United States|Organizations established in 1958|Life sciences industry|Pharmaceutical industry trade groups|Health industry trade groups based in the United States|Medical and health organizations based in Washington, D.C. |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。